IMDX Insight Molecular Diagnostics Inc. - Common Stock
$4.36
价格 · 八月 19, 2026
截至...的财报数据 八月 10, 2026
52周区间
$2–$9
33% of range
分析师评级
BUY
10 analysts
目标价
$8
+91% upside
P/E (TTM)
-2.6
ROE
330.8%
净利润率
-1238.5%
IMDX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.36
市值
$125M
P/E (TTM)
-2.6
每股收益 (TTM)
$-1.65
营收 (TTM)
$4M
股息收益率
—
ROE
330.8%
负债/权益
—
52周区间
$2 – $9
IMDX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$4M
2020-12-31
→
2025-12-31
EPS
$-1.65
2022-12-31
→
2025-12-31
自由现金流
$-25M
2016-12-31
→
2025-12-31
利润率
-1238.5%
2023-12-31
→
2025-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
IMDX
同行中位数
P/E (TTM)
-2.6
—
P/S (TTM) (市销率 (TTM))
30.8
28.5
P/B (市净率)
-4.0
2.2
Price / FCF (股价/自由现金流)
-4.9
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
IMDX
同行中位数
Gross Margin (毛利率)
56.7%
51.3%
Operating Margin (营业利润率)
-1260.8%
—
Net Profit Margin (净利润率)
-1238.5%
-1348.1%
ROA
-165.1%
-100.0%
ROE
330.8%
-154.7%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
IMDX
同行中位数
Current Ratio (流动比率)
1.3
2.9
Quick Ratio (速动比率)
1.1
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
IMDX
同行中位数
Revenue YoY (营收同比增长)
115.6%
—
Revenue CAGR 3Y (营收3年复合年增长率)
61.8%
—
Revenue CAGR 5Y (营收5年复合年增长率)
27.2%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
IMDX
同行中位数
IMDX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
10 位分析师
- 强烈买入 2 20.0%
- 买入 5 50.0%
- 持有 3 30.0%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
3 位分析师 · 2026-08-18
中位数
$9.00
平均值
$8.33
现在
$4.36
最低
$4.00
最高
$12.00
中位数目标
$9.00
+106.4%
平均目标
$8.33
+91.1%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.29%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.23 | $-0.25 | 0.02% |
| 2026年3月31日 | $-0.12 | $-0.27 | 0.15% |
| 2025年12月31日 | $-0.72 | $-0.24 | -0.48% |
| 2025年9月30日 | $-0.34 | $-0.21 | -0.13% |
| 2025年6月30日 | $-0.30 | $-0.23 | -0.07% |
| 2025年3月31日 | $-0.26 | $-0.24 | -0.02% |
| 2024年12月31日 | $-1.93 | $-0.44 | -1.5% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| HURA | — | -1.2 | — | — | — | — |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | — |
| OTLK | $57M | -0.6 | — | -4416.2% | 193.1% | 4.0% |
| CBUS | — | -0.6 | -14.6% | -3492.3% | -223.0% | — |
| ANIX | $136M | -12.1 | 0.00% | — | -62.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Cost of Revenue | $2M | $1M | $1M | $880.0K | $697.0K | $2M | · | · | · | · | · | |
| Gross Profit | $2M | $740.0K | $413.0K | $-18.0K | $1M | $-639.0K | · | · | · | · | · | |
| R&D Expense | $16M | $10M | $9M | $7M | $5M | $10M | $7M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $11M | $10M | $11M | $22M | $22M | $17M | $13M | $7M | $9M | $4M | $4M | |
| Operating Expenses | $53M | $62M | $26M | $18M | $55M | $29M | $22M | $15M | $19M | $11M | $9M | |
| Operating Income | $-51M | $-61M | $-25M | $-18M | $-54M | $-30M | $-22M | $-15M | $-19M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $18.0K | |
| Other Non-op | $1M | $462.0K | $394.0K | $-61.0K | $-37.0K | $27.0K | $-3.0K | $91.0K | $-309.0K | $0 | $2.0K | |
| Pretax Income | · | $-61M | $-25M | $-19M | $-53M | $-31M | $-22M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | $-9M | $-1M | · | · | · | · | · | |
| Net Income | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| EPS (Basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · | |
| Shares (Basic) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | 88,920 | · | · | · | · | · | · | |
| Shares (Diluted) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | · | · | · | · | · | · | · | |
| EBITDA | $-49M | $-59M | $-25M | · | · | · | · | · | · | $-11M | · |
资产负债表 25
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $9M | $9M | $20M | $33M | $7M | $22M | $8M | $8M | $10M | $8M | |
| Receivables | $1M | $2M | $484.0K | $2M | $1M | $203.0K | · | · | · | · | · | |
| Inventory | $446.0K | $410.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $821.0K | $643.0K | $977.0K | $901.0K | $1M | $505.0K | $180.0K | $168.0K | $285.0K | $388.0K | |
| Other Current Assets | · | · | · | · | $85.0K | $295.0K | $36.0K | $78.0K | · | $103.0K | $22.0K | |
| Current Assets | $15M | $12M | $11M | $26M | $39M | $9M | $23M | $9M | $9M | $13M | $11M | |
| PP&E (Net) | $6M | $6M | $5M | $9M | $7M | $4M | $4M | $614.0K | $822.0K | $688.0K | $576.0K | |
| PP&E (Gross) | · | · | · | · | $7M | $2M | $1M | $2M | $1M | $1M | $750.0K | |
| Accum. Depreciation | $7M | $8M | $6M | $4M | $3M | $1M | $343.0K | $948.0K | $657.0K | $319.0K | $174.0K | |
| Goodwill | · | · | · | · | $19M | $9M | · | · | · | · | · | |
| Intangibles | $0 | $15M | $57M | $62M | $62M | $15M | · | · | $746.0K | $988.0K | $1M | |
| Other Non-current Assets | $593.0K | $691.0K | $463.0K | $371.0K | $264.0K | $356.0K | $93.0K | · | · | · | · | |
| Total Assets | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Accounts Payable | $3M | $2M | $953.0K | $1M | $2M | $432.0K | $469.0K | $166.0K | $175.0K | $422.0K | $285.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | · | · | $636.0K | $549.0K | $325.0K | |
| Current Liabilities | $12M | $7M | $7M | $12M | $14M | $9M | $4M | $6M | $4M | $4M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | $187.0K | $289.0K | $310.0K | $0 | |
| Total Liabilities | $57M | $47M | $49M | $60M | $94M | $22M | $9M | $6M | $6M | $5M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $2M | · | · | |
| Common Stock | $369M | $338M | $310M | $295M | $253M | $157M | $125M | $75M | $60M | $46M | $35M | |
| Retained Earnings | $-401M | $-351M | $-290M | $-261M | $-188M | $-124M | $-94M | $-71M | $-55M | $-35M | $-24M | |
| AOCI | $86.0K | $21.0K | $49.0K | $39.0K | $37.0K | · | · | · | $-888.0K | $-654.0K | $-350.0K | |
| Stockholders' Equity | $-31M | $-12M | $20M | $34M | $65M | $33M | $31M | $3M | $4M | $10M | $10M | |
| Liabilities + Equity | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Shares Outstanding | 28,683,000 | 17,453,000 | 8,261,000 | 5,932,000 | 92,232,000 | 69,117,000 | 57,032,000 | 40,664,000 | 31,452,000 | 28,737,000 | 25,391,000 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $800.0K | $313.0K | · | · | · | · | · | |
| Stock-based Comp | $2M | $2M | $3M | $10M | $7M | $5M | $3M | $1M | $2M | · | · | |
| Deferred Tax | · | · | $0 | $0 | $-9M | $-1M | · | · | · | · | · | |
| Amort. of Intangibles | $7.0K | $88.0K | $88.0K | $4M | $3M | $81.0K | · | $121.0K | $242.0K | $242.0K | $242.0K | |
| Other Non-cash | $24M | $37M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-46M | $-36M | $-26M | $-20M | $-12M | $-13M | $-8M | $-4M | |
| CapEx | $3M | $516.0K | $281.0K | $4M | $2M | $1M | $918.0K | $31.0K | $91.0K | $106.0K | $500.0K | |
| Investing Cash Flow | $-3M | $-512.0K | $-932.0K | $-4M | $-14M | $-12M | $-12M | $-31.0K | $843.0K | $-181.0K | $315.0K | |
| Debt Issued | · | · | · | · | · | $1M | · | · | · | · | · | |
| Stock Issued | $29M | $26M | $14M | $33M | $65M | $18M | $49M | $10M | · | $0 | $12M | |
| Net Stock Activity | $29M | $26M | $14M | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $28M | $20M | $12M | $36M | $78M | $23M | $48M | $12M | $10M | $10M | $12M | |
| Net Change in Cash | $3M | $-796.0K | $-12M | $-14M | $28M | $-15M | $16M | $434.0K | $-3M | $2M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-24M | · | · | · | · | · | · | $-8M | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.7% | 39.3% | 27.5% | · | · | · | · | · | · | · | · | |
| Operating Margin | -1260.8% | -3245.1% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | · | · | · | · | · | · | 39885.7% | · | |
| Pretax Margin | · | -3225.0% | -1653.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1206.6% | -3162.0% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| ROA | -165.1% | -110.3% | -31.8% | · | · | · | · | · | · | -82.2% | · | |
| ROE | 330.8% | 4733.8% | -98.2% | · | · | · | · | · | · | -110.1% | · | |
| ROIC | · | 497.3% | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.6 | 1.5 | · | · | · | · | · | · | 3.0 | · | |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · | · | · | · | · | 2.4 | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | -0.0 | · | |
| Inventory Turnover | 4.1 | 5.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.0 | 1.8 | 2.8 | · | · | · | · | · | · | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 61.8% | -5.1% | 7.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Net Income TTM | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| Market Cap | $215M | $42M | $21M | · | · | · | · | · | · | $4.05B | · | |
| P/E | -4.5 | -0.5 | -0.7 | -0.5 | · | · | · | · | · | · | · | |
| P/S | 53.1 | 22.1 | 13.7 | · | · | · | · | · | · | · | · | |
| P/B | -6.8 | -3.4 | 1.0 | · | · | · | · | · | · | 410.9 | · | |
| P / Tangible Book | · | · | · | · | · | 355.7 | · | · | · | · | · | |
| P / Cash Flow | -9.7 | -2.0 | -0.9 | · | · | · | · | · | · | -538.7 | · | |
| P / FCF | -8.5 | -2.0 | -0.9 | · | · | · | · | · | · | -531.2 | · | |
| Earnings Yield | -22.0% | -195.8% | -150.0% | -206.4% | · | · | · | · | · | · | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $1M | $260.0K | $518.0K | $2M | $1M | $115.0K | $104.0K | $176.0K | $314.0K | $429.0K | $463.0K | $297.0K | $274.0K | $67.0K | |
| Cost of Revenue | $82.0K | $17.0K | $655.0K | $121.0K | $180.0K | $813.0K | $869.0K | $43.0K | $32.0K | $109.0K | $409.0K | $159.0K | $169.0K | $265.0K | $278.0K | $314.0K | |
| Gross Profit | $157.0K | $15.0K | $484.0K | $139.0K | $338.0K | $1M | $595.0K | $50.0K | $50.0K | $45.0K | $-117.0K | $248.0K | $272.0K | $10.0K | $-27.0K | $-269.0K | |
| R&D Expense | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $4M | $3M | $5M | $6M | |
| Operating Expenses | $12M | $4M | $24M | $11M | $10M | $8M | $34M | $14M | $5M | $9M | $16M | $7M | $9M | $-6M | $12M | $1M | |
| Operating Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-14M | $-5M | $-9M | $-16M | $-7M | $-8M | $6M | $-12M | $-2M | |
| Other Non-op | $162.0K | $146.0K | $506.0K | $223.0K | $125.0K | $157.0K | $146.0K | $53.0K | $110.0K | $153.0K | $269.0K | $127.0K | $-1.0K | $-1.0K | $-365.0K | $62.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $6M | $-12M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $3M | $-45M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| EPS (Diluted) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| Shares (Basic) | 36,750,000 | 34,519,000 | -59,274,000 | 32,033,000 | 32,023,000 | 25,694,000 | -21,777,000 | 13,714,000 | 12,870,000 | 8,264,000 | -14,653,000 | 8,256,000 | 8,090,000 | 5,958,000 | -86,714,583 | 5,931 | |
| Shares (Diluted) | 36,750,000 | 34,519,000 | -59,274,000 | 32,033,000 | 32,023,000 | 25,694,000 | -21,777,000 | 13,714,000 | 12,870,000 | 8,264,000 | -14,658,000 | 8,256,000 | 8,090,000 | 5,963,000 | -86,714,583 | 5,931 | |
| EBITDA | $-11M | $-4M | · | $-10M | $-9M | $-6M | · | $-14M | $-5M | $-9M | · | $-7M | $-8M | $6M | · | $-9M |
资产负债表 21
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $28M | $12M | $19M | $24M | $31M | $9M | $3M | $9M | $6M | $9M | $14M | $17M | $12M | $20M | $32M | |
| Receivables | $192.0K | $157.0K | $1M | $258.0K | $512.0K | $4M | $2M | $209.0K | $85.0K | $161.0K | $484.0K | $2M | $2M | $2M | $2M | $2M | |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | $821.0K | $627.0K | $595.0K | $735.0K | $643.0K | $672.0K | $1M | $970.0K | $977.0K | $2M | |
| Current Assets | $21M | $31M | $15M | $21M | $27M | $36M | $12M | $5M | $10M | $7M | $11M | $17M | $21M | $16M | $26M | $37M | |
| PP&E (Net) | $6M | $9M | $9M | $6M | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $7M | $8M | $9M | $9M | |
| Accum. Depreciation | $8M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19M | |
| Intangibles | · | · | $0 | $15M | $15M | $15M | $15M | $57M | $57M | $57M | $57M | $57M | $57M | $57M | $62M | $88M | |
| Other Non-current Assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K | $563.0K | $438.0K | $463.0K | $520.0K | $329.0K | $367.0K | $371.0K | $366.0K | |
| Total Assets | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Accounts Payable | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $872.0K | $1M | $908.0K | $953.0K | $1M | $875.0K | $1M | $1M | $2M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $1M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $4M | |
| Current Liabilities | $10M | $12M | $12M | $8M | $7M | $10M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | $9M | $12M | $13M | |
| Total Liabilities | $51M | $51M | $57M | $53M | $49M | $50M | $47M | $61M | $52M | $54M | $49M | $39M | $39M | $39M | $60M | $75M | |
| Common Stock | $395M | $394M | $369M | $369M | $368M | $367M | $338M | $327M | $326M | $311M | $310M | $310M | $310M | $296M | $295M | $293M | |
| Retained Earnings | $-416M | $-405M | $-401M | $-378M | $-367M | $-357M | $-351M | $-317M | $-304M | $-299M | $-290M | $-272M | $-266M | $-258M | $-261M | $-216M | |
| AOCI | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K | $37.0K | $40.0K | $49.0K | $32.0K | $41.0K | $43.0K | $39.0K | $19.0K | |
| Stockholders' Equity | $-21M | $-11M | $-31M | $-9M | $1M | $10M | $-12M | $10M | $23M | $12M | $20M | $38M | $44M | $38M | $34M | $77M | |
| Liabilities + Equity | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Shares Outstanding | 32,623,000 | 32,286,000 | 28,683,000 | 28,625,000 | 28,617,000 | 28,599,000 | 17,453,000 | 13,374,000 | 13,368,000 | 8,273,000 | 8,261,000 | 8,261,000 | 8,241,000 | 119,279,000 | 5,932,000 | 118,619,000 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $665.0K | $631.0K | $563.0K | $584.0K | $559.0K | $491.0K | $563.0K | $340.0K | $326.0K | $335.0K | $303.0K | $404.0K | $435.0K | $450.0K | $466.0K | $391.0K | |
| Stock-based Comp | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K | $386.0K | $418.0K | $484.0K | $608.0K | $834.0K | $834.0K | $3M | $3M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | $7.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $812.0K | $976.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-151.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-6M | $-5M | $-6M | $-6M | $-5M | $-6M | $-6M | $-4M | $-4M | $-2M | $-5M | $-8M | $-10M | $-11M | |
| CapEx | $779.0K | $613.0K | $1M | $1M | $349.0K | $307.0K | $214.0K | $87.0K | $191.0K | $24.0K | $264.0K | · | · | · | $802.0K | $859.0K | |
| Investing Cash Flow | $-779.0K | $-613.0K | $-1M | $-1M | $-349.0K | $-307.0K | $-210.0K | $-87.0K | $-191.0K | $-24.0K | $103.0K | $-1M | $123.0K | $-1M | $-802.0K | $-859.0K | |
| Stock Issued | $0 | $26M | $0 | $0 | $0 | $29M | $10M | $0 | $16M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $26M | · | · | · | $29M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-564.0K | $25M | $-252.0K | $-120.0K | $-114.0K | $29M | $11M | $-255.0K | $10M | $0 | $-30.0K | $-30.0K | $12M | $-28.0K | $-100.0K | $-572.0K | |
| Net Change in Cash | $-11M | $16M | $-7M | $-6M | $-7M | $22M | $5M | $-6M | $4M | $-4M | $-4M | $-4M | $6M | $-10M | $-11M | $-13M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-8M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | · | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 46.9% | · | 53.5% | 67.6% | 62.0% | · | 43.5% | 48.1% | -55.7% | · | 57.8% | 58.8% | 3.4% | · | -115.4% | |
| Operating Margin | -4770.7% | -13790.6% | · | -4249.2% | -1900.0% | -318.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| Net Margin | -4711.3% | -13406.2% | · | -4174.6% | -1880.7% | -312.0% | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 1021.2% | · | -917.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 2006.4% | · | -917.7% | |
| EBITDA Margin | -4492.5% | -11818.8% | · | -4024.6% | -1792.1% | -295.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| ROA | -28.2% | -8.5% | · | -19.0% | -15.6% | -10.2% | · | -17.8% | -5.6% | -11.9% | · | -5.4% | -6.4% | 2.6% | · | -5.7% | |
| ROE | 111.5% | 1814.0% | · | -4215.1% | -81.9% | -61.2% | · | -57.1% | -13.7% | -36.9% | · | -11.3% | -13.1% | 6.4% | · | -10.6% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.5 | · | 2.8 | 4.0 | 3.7 | · | 0.5 | 1.4 | 0.8 | · | 2.1 | 2.7 | 1.7 | · | 2.8 | |
| Quick Ratio | 1.7 | 2.4 | · | 2.5 | 3.7 | 3.6 | · | 0.4 | 1.3 | 0.7 | · | 2.0 | 2.5 | 1.5 | · | 2.6 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.0 | · | 0.3 | 0.5 | 3.5 | · | 0.4 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 0.0 | · | 1.1 | 1.7 | 1.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.3 | 0.1 | · | 0.7 |
估值 (TTM) 9
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $3M | · | $3M | $3M | $3M | · | $824.0K | $1M | $1M | · | $1M | $1M | $981.0K | · | $4M | |
| Net Income TTM | $-36M | $-32M | · | $-41M | $-34M | $-34M | · | $-34M | $-28M | $-21M | · | $-21M | $-23M | $-25M | · | $-64M | |
| Market Cap | $192M | $106M | · | $95M | $86M | $88M | · | $38M | $39M | $24M | · | $26M | $38M | $844M | · | $1.73B | |
| P/E | -5.5 | -3.2 | · | -1.8 | -1.6 | -1.1 | · | -0.9 | -0.9 | -1.1 | · | -1.0 | -1.2 | -2.5 | · | · | |
| P/S | 183.5 | 35.9 | · | 31.4 | 30.1 | 34.5 | · | 46.3 | 33.6 | 17.8 | · | 20.5 | 35.6 | 860.9 | · | 405.3 | |
| P/B | -9.0 | -9.9 | · | -10.3 | 78.7 | 8.6 | · | 3.9 | 1.7 | 2.1 | · | 0.7 | 0.9 | 22.3 | · | 22.5 | |
| P / Cash Flow | · | -13.9 | · | · | · | -14.9 | · | · | · | -6.3 | · | · | · | -87.3 | · | · | |
| P / FCF | · | -12.8 | · | · | · | -14.2 | · | · | · | -6.3 | · | · | · | · | · | · | |
| Earnings Yield | -18.1% | -31.1% | · | -56.6% | -62.9% | -89.2% | · | -115.1% | -114.2% | -89.1% | · | -99.4% | -82.0% | -39.7% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $4M | $2M | $2M | $958.0K | $2M |
| 毛利率 % | 56.7% | 39.3% | 27.5% | — | — |
| 营业利润率 % | -1260.8% | -3245.1% | -1672.4% | — | — |
| 净收入 | $-50M | $-61M | $-28M | $-73M | $-64M |
| 稀释后每股收益 (EPS) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | — |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 1.3 | 1.6 | 1.5 | — | — |
| 速动比率 | 1.1 | 1.4 | 1.4 | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-25M | $-21M | $-24M | — | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 44 家申报者 · $106.4M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 15 (-2 与上一季度对比) | 13 (+6 与上一季度对比) | 8 (-1 与上一季度对比) | 7 (0 与上一季度对比) | -519K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 18 位内幕人士 · 8 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Ronald Asbury Andrews | Chief Executive Officer | 2019年7月1日 A | — | 0 | 0 | $0 |
| William Annett | President and CEO | 2019年3月14日 A | — | 0 | 0 | $0 |
| Mitchell S Levine | Chief Financial Officer | 2019年9月12日 P | 10000 | 0 | 0 | $0 |
| Albert P Parker | Chief Operating Officer | 2019年3月14日 A | — | 0 | 0 | $0 |
| Tony T Kalajian | SVP-Chief Accounting Officer | 2019年9月13日 P | 10000 | 0 | 0 | $0 |
| Lyndal K. Hesterberg | Chief Scientific Officer | 2019年3月14日 A | — | 0 | 0 | $0 |
| Kristine C. Mechem | VP of Marketing | 2018年6月7日 A | — | 0 | 0 | $0 |
| Karen B. Chapman | Vice President of Research | 2016年2月16日 A | — | 0 | 0 | $0 |
| Andrew J. Last | 董事 | 2026年7月1日 F | 58752 | 0 | 0 | $0 |
| Andrew Arno | 董事 | 2026年7月1日 F | 156785 | 0 | 0 | $0 |
| Lou Silverman | 董事 | 2026年7月1日 F | 55807 | 0 | 0 | $0 |
| Aditya P. Mohanty | 董事 | 2019年7月17日 A | — | 0 | 0 | $0 |
| Cavan M. Redmond | 董事 | 2019年7月17日 A | — | 0 | 0 | $0 |
| Alfred D Kingsley | 董事 | 2019年7月17日 A | — | 0 | 0 | $0 |
| Don M Bailey | 董事 | 2017年6月15日 A | — | 0 | 0 | $0 |
| Michael D West | 董事 | 2016年2月16日 A | — | 0 | 0 | $0 |
| BIOTIME INC | 10% 所有者 | 2019年7月5日 S | 12424244 | 0 | 0 | $0 |
| John Peter Gutfreund | — | 2023年6月30日 J | 0 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 申报 | 2026年4月27日 | 39.70% | 修订 | 被动投资 | SEC |
| Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 申报 | 2021年1月8日 | — | 初始申报 | — | SEC |
| BioTime, Inc. 1 S.S. OR ×5 申报 | 2019年7月5日 | — | 初始申报 | — | SEC |
| BioTime, Inc. S.S. OR | 2016年8月29日 | — | 初始申报 | 董事会活动 | SEC |
| BioTime, Inc. | 2015年12月31日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。